A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors

Clinical trial NCT05538572 · COMPLETED

Trial details

NCT number: NCT05538572
Sponsor: Prelude Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Cancer Glioblastoma Head and Neck Squamous Cell Carcinoma Malignant Mesothelioma Non-small Cell Lung Cancers Sarcoma Endometrial Cancer

Start date: 2022-12-27
Primary completion: 2024-06-26
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.